EUVIMEDEUVIMED entdecken
Crossref

HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion

Yongkang Yang iD, Qiaozhu Zuo iD, Vijay Ramu iD, Varen Talwar iD, Yajing Lyu iD, Chelsey Chen iD, Daiana Drehmer iD, Tina Yi-Ting Huang iD, Shaima Salman iD, Dominic Dordai iD, Yufeng Wang iD, Emmanuel Datan iD und 2 weitere

Journal of Experimental Medicine · 02.03.2026 · 223 (3)

DOI: 10.1084/jem.20250777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 12.12.2025. Verfasst von Yongkang Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Armstrong Oxygen Biology Research Center and Institute for Cell Engineering, Johns Hopkins University School of Medicine , Baltimore, MD, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Triple Negative Breast Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit, Immune Evasion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Armstrong Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype with the highest rates of recurrence, metastasis, and patient mortality due to the absence of effective therapies. Hypoxia-inducible factor 1 (HIF-1) regulates the expression of thousands of RNAs in TNBC. Here, we demonstrate that transcription of the ISG20 gene, which encodes an RNA exonuclease, is activated by HIF-1 in TNBC cells. ISG20-mediated degradation of RHOBTB3 mRNA increases HIF-1α protein expression and activates NANOG signaling, which increases breast cancer stem cell specification and lung metastasis. ISG20 also degrades STAT1 and IRF1 mRNAs, leading to decreased expression of CXCL10 and impaired recruitment of CD8+ T cells and natural killer cells, thereby promoting breast cancer immune evasion. Silencing ISG20 increases the sensitivity of mouse TNBC cells to anti-PD1 antibody immune checkpoint blockade. Our data suggest that targeting ISG20, in combination with immunotherapy, could be an effective therapeutic strategy for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsTriple Negative Breast NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitImmune EvasionExoribonucleasesHumansAnimalsFemaleCell Line, TumorMiceGene Expression Regulation, NeoplasticSTAT1 Transcription FactorSignal TransductionCD8-Positive T-LymphocytesLung Neoplasms

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitExoribonucleasesSTAT1 Transcription FactorHIF1A protein, human

Autor:innen und Institutionen

  • Armstrong Oxygen Biology Research Center and Institute for Cell Engineering, Johns Hopkins University School of Medicine , Baltimore, MD, USA.
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins , Baltimore, MD, USA.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Johns Hopkins University , Baltimore, MD, USA.
  • Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Yongkang Yang, Qiaozhu Zuo, Vijay Ramu, Varen Talwar, Yajing Lyu, Chelsey Chen, Daiana Drehmer, Tina Yi-Ting Huang, Shaima Salman, Dominic Dordai, Yufeng Wang, Emmanuel Datan, Elizabeth E Wicks, Gregg L Semenza

Förderung

  • Armstrong Family Foundation

Zitieren

APA

Yang, Y., Zuo, Q., Ramu, V., Talwar, V., Lyu, Y., Chen, C., Drehmer, D., Yi-Ting Huang, T., Salman, S., Dordai, D., Wang, Y., Datan, E., Wicks, E. E., & Semenza, G. L. (2026). HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion. Journal of Experimental Medicine, 223(3). https://doi.org/10.1084/jem.20250777

Vancouver

Yang Y, Zuo Q, Ramu V, Talwar V, Lyu Y, Chen C, et al. HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion. Journal of Experimental Medicine. 2026;223(3). doi:10.1084/jem.20250777

BibTeX
@article{Yang2026,
  author = {Yang, Yongkang and Zuo, Qiaozhu and Ramu, Vijay and Talwar, Varen and Lyu, Yajing and Chen, Chelsey and Drehmer, Daiana and Yi-Ting Huang, Tina and Salman, Shaima and Dordai, Dominic and Wang, Yufeng and Datan, Emmanuel and Wicks, Elizabeth E and Semenza, Gregg L},
  title = {HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {3},
  doi = {10.1084/jem.20250777}
}
Kostenlos starten →